Talks at NanoString's fourth annual Spatial Genomics Summit shared early results from the CosMx Spatial Molecular Imager (SMI), which is slated for commercial rollout in the second half of 2022.
Spatial Genomics is a California-based biotechnology company that provides services such as spatial single-cell analysis and RNA sequencing for the healthcare industry.